In 2009, it was found that sufferers of Gaucher's disease had a higher risk for this disease because of mutations in GBA.
In 2009, it was found that sufferers of Gaucher's disease had a higher risk for this disease because of mutations in GBA. Selegiline is one drug used to treat this disease, and it functions as an MAO-B inhibitor. In this disease, ubiquitin forms complexes with alpha-synuclein, leading to Lewy body formation in the substantia nigra. William Knowles and Arvid Carlsson both won Nobel Prizes for their work on a treatment for this disease that can cross the blood-brain barrier, called L-DOPA. Name this disease, with symptoms such as shaking, rigidity, and slowness of movement, which is caused by a lack of dopamine in the brain.
In 2009, it was found that sufferers of Gaucher's disease had a higher risk for this disease because of mutations in GBA.
{Parkinson}’s disease [or {PD}]